Institute of Brain, Behaviour and Mental Health, University of Manchester, Machester, United Kingdom.
JMIR Mhealth Uhealth. 2015 Nov 6;3(4):e102. doi: 10.2196/mhealth.4930.
There is increasing interest in using mobile technologies such as smartphones for improving the care of patients with schizophrenia. However, less is known about the current clinical evidence for the feasibility and effectiveness of smartphone apps in this population.
To review the published literature of smartphone apps applied for the care of patients with schizophrenia and other psychotic disorders.
An electronic database search of Ovid MEDLINE, the Cochrane Central Register of Controlled Trials, Health Technology Assessment Database, Allied and Complementary Medicine, Health and Psychosocial Instruments, PsycINFO, and Embase was conducted on May 24, 2015. All eligible studies were systematically reviewed, and proportional meta-analyses were applied to pooled data on recruitment, retention, and adherence to examine the overall feasibility of smartphone interventions for schizophrenia.
Our search produced 226 results from which 7 eligible articles were identified, reporting on 5 studies of smartphone apps for patients with schizophrenia. All examined feasibility, and one assessed the preliminary efficacy of a smartphone intervention for schizophrenia. Study lengths varied between 6 and 130 days. Overall retention was 92% (95% CI 82-98%). Participants consistently used the smartphone apps on more than 85% of days during the study period, averaging 3.95 interactions per person per day. Furthermore, participants responded to 71.9% of automated prompts (95% CI 65.7-77.8%). Participants reported a range of potential benefits from the various interventions, and user experience was largely positive.
Although small, the current published literature demonstrates strong evidence for the feasibility of using smartphones to enhance the care of people with schizophrenia. High rates of engagement and satisfaction with a broad range of apps suggest the nascent potential of this mobile technology. However, there remains limited data on the efficacy of such interventions.
人们对使用智能手机等移动技术改善精神分裂症患者护理的兴趣日益浓厚。然而，对于智能手机应用在该人群中的可行性和有效性的现有临床证据知之甚少。
综述已发表的用于精神分裂症患者和其他精神病患者护理的智能手机应用文献。
于 2015 年 5 月 24 日对 Ovid MEDLINE、Cochrane 对照试验中心注册库、卫生技术评估数据库、补充和综合医学、健康和心理社会仪器、PsycINFO 和 Embase 电子数据库进行了检索。对所有合格的研究进行了系统评价，并对招募、保留和坚持的汇总数据进行了比例荟萃分析，以检查智能手机干预措施在精神分裂症中的总体可行性。
我们的检索产生了 226 个结果，从中确定了 7 篇合格的文章，报告了 5 项针对精神分裂症患者智能手机应用的研究。所有研究均检查了可行性，其中 1 项评估了智能手机干预精神分裂症的初步疗效。研究时间长度从 6 天到 130 天不等。总体保留率为 92%（95%CI 82%-98%）。参与者在研究期间始终每天使用智能手机应用程序超过 85%，平均每人每天 3.95 次交互。此外，参与者对 71.9%的自动提示做出了回应（95%CI 65.7%-77.8%）。参与者报告了各种干预措施的一系列潜在益处，并且用户体验大多是积极的。
尽管规模较小，但目前已发表的文献为使用智能手机增强精神分裂症患者护理的可行性提供了强有力的证据。对广泛应用程序的高参与率和满意度表明这种移动技术具有巨大的潜力。然而，关于此类干预措施的疗效数据仍然有限。
Zotero 插件